Clinical trials
Phase 1/2 Nasopharyngeal Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 10 |
| Terminated | 6 |
| Recruiting | 5 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Proton and Heavy Ion Center | 3 |
| Sun Yat-sen University | 3 |
| Shanghai Junshi Bioscience Co., Ltd. | 2 |
| Alberta Health services | 1 |
| Arvinas Inc. | 1 |
| Atara Biotherapeutics | 1 |
| Chinese Academy of Medical Sciences | 1 |
| Cullinan Therapeutics Inc. | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| Genmab | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 36 |
| Nasopharyngeal Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Head and Neck Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Uterine Cervical Neoplasms | 3 |
| Carcinoma | 2 |
| Carcinoma, Transitional Cell | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 76 to 36 of 36. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.